Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $428.86 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $219.97 | 14 | $0 (2024) |
| Exact Sciences Corporation | $58.57 | 3 | $0 (2024) |
| Quidel Corporation | $43.08 | 1 | $0 (2023) |
| PFIZER INC. | $33.78 | 2 | $0 (2023) |
| AbbVie Inc. | $20.86 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $19.93 | 1 | $0 (2023) |
| Amgen Inc. | $19.77 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $12.90 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.67 | 2 | Novo Nordisk Inc ($20.57) |
| 2023 | $192.03 | 9 | Novo Nordisk Inc ($49.88) |
| 2022 | $80.16 | 5 | Novo Nordisk Inc ($51.38) |
| 2021 | $119.00 | 8 | Novo Nordisk Inc ($98.14) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Oncology | ||||||
| 05/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Obesity | ||||||
| 08/02/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Inflammation | ||||||
| 04/10/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 04/05/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, PAXLOVID | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: WOMENS HEALTH | ||||||
| 03/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Oncology | ||||||
| 02/28/2023 | Quidel Corporation | Sofia (Device) | Food and Beverage | In-kind items and services | $43.08 | General |
| Category: Diagnostics | ||||||
| 02/22/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Diabetes | ||||||
| 02/15/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Oncology | ||||||
| 02/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Diabetes | ||||||
| 11/14/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/13/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 05/19/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 04/19/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: VACCINES | ||||||
| 03/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Diabetes | ||||||
| 10/27/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 08/26/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Diabetes | ||||||
| 08/11/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Diabetes | ||||||
| 07/15/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Diabetes | ||||||
| 07/01/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 04/14/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Diabetes | ||||||
| 02/25/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: IMMUNOLOGY | ||||||
| 02/04/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 522 | 1,530 | $163,790 | $59,925 |
| 2022 | 8 | 315 | 967 | $150,958 | $52,721 |
| 2021 | 10 | 375 | 842 | $73,183 | $41,077 |
| 2020 | 2 | 49 | 73 | $10,778 | $5,964 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 543 | $105,727 | $37,018 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 93 | $27,816 | $9,877 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $6,800 | $2,624 | 38.6% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2023 | 42 | 55 | $2,750 | $2,440 | 88.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $3,678 | $2,244 | 61.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 43 | 99 | $2,970 | $1,606 | 54.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 11 | $1,430 | $779.35 | 54.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 88 | $3,075 | $707.34 | 23.0% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 14 | 21 | $1,540 | $671.84 | 43.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 15 | 16 | $1,312 | $607.88 | 46.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 15 | $1,050 | $514.20 | 49.0% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 35 | 88 | $1,980 | $372.74 | 18.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 26 | 408 | $2,712 | $332.12 | 12.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 38 | $950.00 | $129.58 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 577 | $125,991 | $43,344 | 34.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 38 | $9,478 | $4,491 | 47.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $8,585 | $3,337 | 38.9% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 17 | 24 | $1,800 | $767.66 | 42.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 27 | 59 | $1,787 | $426.93 | 23.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 53 | 64 | $341.50 | $191.55 | 56.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 139 | $1,900 | $114.93 | 6.0% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2022 | 17 | 23 | $1,075 | $47.24 | 4.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 394 | $51,622 | $32,577 | 63.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 63 | 63 | $12,499 | $5,393 | 43.2% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 15 | 25 | $1,803 | $832.70 | 46.2% |
About James Watson, DNP-BC
James Watson, DNP-BC is a Adult Health healthcare provider based in Jasper, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2012. The National Provider Identifier (NPI) number assigned to this provider is 1659637312.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Watson, DNP-BC has received a total of $428.86 in payments from pharmaceutical and medical device companies, with $37.67 received in 2024. These payments were reported across 24 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($428.86).
As a Medicare-enrolled provider, Watson has provided services to 1,261 Medicare beneficiaries, totaling 3,412 services with total Medicare billing of $159,687. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Other Specialties Adult Health
- Location Jasper, FL
- Active Since 04/07/2012
- Last Updated 10/06/2023
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1659637312
Products in Payments
- Ozempic (Drug) $147.30
- Cologuard Collection Kit (Device) $58.57
- Sofia (Device) $43.08
- RYBELSUS (Drug) $31.70
- HUMIRA (Biological) $20.86
- Wegovy (Drug) $20.57
- Rybelsus (Drug) $20.40
- BELSOMRA (Drug) $19.93
- Otezla (Drug) $19.77
- PREMARIN (Drug) $17.90
- ELIQUIS (Drug) $15.88
- SHINGRIX (Biological) $12.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Jasper
Brooke Childers, Np, NP
Adult Health — Payments: $485.20
Mrs. Linda Sides, Anp, ANP
Adult Health — Payments: $24.95
Nadia Martindale, Msn, Apn, Acns-Bc, MSN, APN, ACNS-BC
Adult Health — Payments: $20.57
Delores Tucker, Rn, Aprn, Gcns-Bc, RN, APRN, GCNS-BC
Adult Health
Betty Bridges, Nurse Practitioner, NURSE PRACTITIONER
Adult Health